• Skip to primary navigation
  • Skip to main content
  • Skip to footer
  • Skip to investors navigation
Insmed

Insmed

Powered by Purpose

LinkedIn Twitter Contact Us Job Opportunities

  • Culture
    • Our Culture
      • Mission & Vision
      • Careers
      • Responsibility
        • Inclusion at Insmed
        • Grants & Funding
        • Global Healthcare Compliance

    Our Global Company

    Find available career opportunities in the U.S., Japan, or Europe.

    Find Jobs

  • Patients
    • Our Patients
      • Disease Areas
      • Resources
      • Patient Access

    Current Clinical Trials

    You may be eligible for one of our clinical trials.

    See if you may qualify

  • Science
    • Our Science
      • ARIKAYCE®
      • Our Research
      • Pipeline
      • Clinical Trials
      • Investigator-Initiated Research

    Our Research

    Working together to develop new medicines and technologies that have the potential to transform patients’ lives.

    Learn More

  • About
    • About Insmed
    • Management Team
    • Board of Directors
    • Partnerships
  • Investors
    • Investors
    • Events & Presentations
    • Stock Information
    • News Releases
    • SEC Filings
    • Annual Reports
    • Analyst Coverage
    • Corporate Governance
    • Email Alerts
    • Investor FAQs
Home/About/Partnerships

Partnerships

Join our fearless fight

Insmed is a global biopharmaceutical company that invests in scientific and commercial innovation to transform the lives of patients with serious and rare diseases. We have expertise in all stages of development, from concept to market, and industry-leading global commercial capabilities in the U.S., major EU markets, and Japan.

We have expertise in all stages of development, from concept to market, and industry-leading global commercial capabilities in the U.S., major EU markets, and Japan.

Insmed’s first commercialized product was a top ten non-oncology rare disease launch (based on first-year sales) in the U.S. We’re building on that success with the expansion of our core franchise in the EU and Japan and a robust pipeline of investigational therapies that have the potential to transform patients’ lives.

For further information on our clinical development programs, view the following resources:

View our pipeline     Investor Events

Download the Investor Presentation

Business development areas of interest

We recognize that global experts in the biopharmaceutical and academic fields who share our profound sense of urgency and patient focus can contribute to our mission to bring life-altering therapies to patients with serious and rare diseases.

We actively seek business development opportunities in the following areas:

  1. Clinical and commercial-stage assets with either first-in-class or best-in-class potential in respiratory and rare diseases
  2. Research, development, and commercialization collaborations that are strategically aligned with our existing portfolio and rare disease focus
  3. Technology platforms that are complementary to our research capabilities and further advance our research efforts into breakthrough science

While we are primarily interested in global in-licensing and acquisition opportunities, we would consider high-potential regional opportunities that leverage our commercialization expertise in the U.S., major EU markets, and Japan.

We are not seeking opportunities for re-purposed medicines, products with modest differentiation from Standard of Care, generics and biosimilars, or cosmetic/OTC products.

Contact us

Our Business Development team is based in the U.S. and covers opportunities globally. We regularly attend major partnering meetings. Reach out to us by email to schedule time to meet or for any partnership inquiries.

MOUSTAPHA EL-AMINE

Head of Corporate and Business Development
BD@insmed.com

Footer

Insmed
LinkedInTwitter

Contact Us

Job Opportunities

  • Our Culture
    • Mission & Vision
    • Careers
    • Responsibility
      • Inclusion at Insmed
      • Grants & Funding
      • Global Healthcare Compliance
  • Our Patients
    • Disease Areas
    • Resources
    • Patient Access
  • Our Science
    • ARIKAYCE®
    • Our Research
    • Pipeline
    • Clinical Trials
    • Investigator-Initiated Research
  • About
    • Management Team
    • Board of Directors
    • Partnerships
  • Investors
  • Events & Presentations
  • Stock Information
  • News Releases
  • SEC Filings
  • Annual Reports
  • Analyst Coverage
  • Corporate Governance
  • Email Alerts
  • Investor FAQs

© 2022 Insmed Incorporated. All Rights Reserved. Terms of Use Privacy Policy

Culture
Patients
Science
logo
  • Culture
    • Mission & Vision
    • Careers
    • Responsibility
      • Inclusion at Insmed
      • Grants & Funding
      • Global Healthcare Compliance
  • Patients
    • Disease Areas
    • Resources
    • Patient Access
  • Science
    • ARIKAYCE®
    • Our Research
    • Pipeline
    • Clinical Trials
    • Investigator-Initiated Research
  • About
    • Management Team
    • Board of Directors
    • Partnerships
  • Investors
    • Events & Presentations
    • Stock Information
    • News Releases
    • SEC Filiings
    • Annual Reports
    • Analyst Coverage
    • Corporate Governance
    • Email Alerts
    • Investor FAQs

LinkedIn Twitter

Contact Us Job Opportunities

© 2021 Insmed Incorporated.
All Rights Reserved.

Terms of Use Privacy Policy